NPRC/Institute
Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd., Rabale, Navi Mubai, India
Summary of Study
Safety, immunogenicity and efficacy of Relcovax®
Year Published
2023
References
DOI: 10.1016/j.vaccine.2023.10.006
Contact Info
R.L. Ramnath: ramnath.l@relbio.com
Keywords
SARS-CoV-2, vaccine, dual receptor binding domain, immune response, safety, several species, primates
Coronavirus Investigated*
date entered
Study Type